Vyome Holdings (HIND) Interest Coverage Ratio (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Interest Coverage Ratio of 7.82 for Q1 2026, down 359.62% year-over-year from 3.01 in Q1 2025, and up 82.83% quarter-over-quarter from 45.56 in Q4 2025.
Vyome Holdings (HIND) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
Vyome Holdings' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 7.82 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 359.62% year-over-year to 7.82; the TTM figure through Mar 2026 stood at 43.65 (down 663.81% YoY), while the FY2025 annual figure was 0.14, down 9.26% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 7.82, up from 45.56 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.05 in Q3 2024, with the low at 334.88 in Q3 2025.
- The 5-year median for Interest Coverage Ratio is 35.09 (2023), against an average of 55.86.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio jumped 98.4% in 2024, then plunged 31697.66% in 2025.
- Vyome Holdings' Interest Coverage Ratio stood at 191.87 in 2022, then jumped by 81.71% to 35.09 in 2023, then surged by 85.57% to 5.06 in 2024, then plunged by 799.68% to 45.56 in 2025, then jumped by 82.83% to 7.82 in 2026.
- Business Quant data shows HIND's Interest Coverage Ratio at 7.82 in Q1 2026, 45.56 in Q4 2025, and 334.88 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | -259.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.04 |
| Mar 31, 2026 | -7.82 |
| Dec 31, 2025 | -45.56 |
| Sep 30, 2025 | -334.88 |
| Jun 30, 2025 | -23.41 |
| Mar 31, 2025 | -1.70 |
| Dec 31, 2024 | -5.06 |
| Sep 30, 2024 | -1.05 |
| Jun 30, 2024 | -8.89 |
| Mar 31, 2024 | -37.46 |
| Dec 31, 2023 | -35.09 |
| Sep 30, 2023 | -65.76 |
| Jun 30, 2023 | -11.73 |
| Mar 31, 2023 | -64.72 |
| Dec 31, 2022 | -191.87 |
| Sep 30, 2022 | -47.31 |
| Jun 30, 2022 | -26.64 |
| Mar 31, 2022 | -40.57 |
| Dec 31, 2021 | -187.58 |
| Sep 30, 2021 | -29.91 |